Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
Trade-Ideas LLC identified
) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified iBio as such a stock due to the following factors:
- IBIO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $50.5 million.
- IBIO has traded 1.9 million shares today.
- IBIO is up 19% today.
- IBIO was down 20.2% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in IBIO with the Ticky from Trade-Ideas. See the FREE profile for IBIO NOW at Trade-Ideas
More details on IBIO:
iBio, Inc., a biotechnology company, focuses on the commercialization of its proprietary plant-based protein expression technologies in the United States and internationally.
The average volume for iBio has been 357,400 shares per day over the past 30 days. iBio has a market cap of $36.8 million and is part of the health care sector and drugs industry. The stock has a beta of 0.90 and a short float of 0.2% with 0.00 days to cover.